The mobile optimisation technology provider, whose backers include Verizon Ventures, is set to be bought by Volaris Group.

Siemens and Scania-backed Sennder has merged with fellow on-demand logistics provider Everoad to seize a larger chunk of the European marketplace.

Genscript Biotech's multiple myeloma-focused spinoff, which counts Eli Lilly and Johnson & Johnson among its investors, has completed an initial public offering in the US.

Capital One and Salesforce-backed cloud database provider Snowflake has confidentially filed for an initial public offering that could value it at up to $20bn.

RWS Holdings had bought language translation software developer Iconic Translation Machines, founded on DCU's research into translating patents.

Johnson & Johnson and Varian Medical Systems are in line for exits after cancer therapy developer Fusion filed for a $100m initial public offering.

The cancer diagnostics technology developer, formed five years ago when Qiagen acquired part of Enzymatics, has filed to float on the Nasdaq Global Market.

McMaster University spinout Fusion Pharmaceuticals has filed for a $100m IPO in the US, putting shareholders such as Facit in line for exits.

Cash Capital has celebrated an exit as UCloudlink raised $36.2m in its offering, after pricing its shares at the bottom of the range and issuing less stock than originally planned.

E-commerce software provider Sirclo, which counts Sinar Mas Land and Beenos Plaza as investors, has joined forces with e-commerce technology and services supplier ICube.